Kevin Ballinger Insider Profile

4 Followers
Kevin Ballinger, EVP & Pres, Interven Cardio at Boston Scientific, holds 0.00 shares in Silk Road Medical (Ticker: SILK), holds 0.00 shares in Shockwave Medical (Ticker: SWAV), holds 80.08K shares in Boston Scientific (Ticker: BSX).
tipranks
Kevin Ballinger

Kevin Ballinger
Boston Scientific (BSX)
EVP & Pres, Interven Cardio

Ranked #66,935 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-20.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
100.00%
0.00%
A breakdown of Kevin Ballinger's holdings

Insider Roles

Boston Scientific
(BSX)
EVP & Pres, Interven Cardio
CVRx
(CVRX)
Director
Roles that Kevin Ballinger holds in companies

Most Profitable Insider Trade

Stock:
Boston Scientific
(BSX)
Rating:Informative Sell
Date:Feb 10, 2015 - Feb 10, 2016
Return:-14.90%
The most profitable trade made by Kevin Ballinger

Kevin Ballinger's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Boston Scientific
Mar 05, 2020
EVP & Pres, Interven Cardio
Uninformative Buy
66.87K
$6.85M
SILK
Silk Road Medical
Sep 18, 2024
Uninformative Sell
$0.00
SWAV
Shockwave Medical
May 31, 2024
Uninformative Sell
$0.00
CVRx
Director
List of latest transactions for each holding click on a transaction to see Kevin Ballinger's performance on stock

Kevin Ballinger insider profile FAQ

What is the percentage of profitable transactions made by Kevin Ballinger?
The percentage of profitable transactions made by Kevin Ballinger is 0%.
    What is the average return per transaction made by Kevin Ballinger?
    The average return per transaction made by Kevin Ballinger is -20.60%.
      What stocks does Kevin Ballinger hold?
      Kevin Ballinger holds: BSX, SILK, SWAV, CVRX stocks.
        What was Kevin Ballinger’s latest transaction?
        Kevin Ballinger latest transaction was an Uninformative Sell of ―.
          What was Kevin Ballinger's most profitable transaction?
          Kevin Ballinger’s most profitable transaction was an Informative Sell of BSX stock on February 10, 2015. The return on the trade was -14.90%.
            What is Kevin Ballinger's role in Boston Scientific?
            Kevin Ballinger's role in Boston Scientific is EVP & Pres, Interven Cardio.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.